Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 32: 142-145, 1986;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alvarez, C.
Right arrow Articles by Ramos, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alvarez, C.
Right arrow Articles by Ramos, A.

Clinical Chemistry, Vol 32, 142-145, Copyright © 1986 by American Association for Clinical Chemistry

Lipids, lipoproteins, and apoproteins in serum during infection

C Alvarez and A Ramos

We studied the alterations in the concentrations of total cholesterol, high-density lipoprotein cholesterol, triglycerides, and apoproteins A and B in serum of 54 patients hospitalized for various reasons, who developed sepsis during their stay. Forty of these patients required intensive care, 14 did not. Another group of patients with the same underlying pathological conditions was used as a control. We found the following: Sepsis causes the concentrations of total cholesterol, high- density lipoprotein cholesterol, and apoproteins A and B in serum to decrease, whereas triglycerides increase. However, these changes are not related to the infectious agent, the underlying illness, or the clinical situation of the patients. The return of serum lipids to more normal concentrations parallels the recovery from sepsis. The positive correlation between the drastically decreased concentrations of high- density lipoprotein cholesterol and the severe hypoalbuminemia in these patients suggests a common pathway for these two abnormalities.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Immunol.Home page
P. A. Thompson and R. L. Kitchens
Native High-Density Lipoprotein Augments Monocyte Responses to Lipopolysaccharide (LPS) by Suppressing the Inhibitory Activity of LPS-Binding Protein
J. Immunol., October 1, 2006; 177(7): 4880 - 4887.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
I. Volanen, O. T. Raitakari, R. Vainionpaa, M. Arffman, J. Aarnisalo, S. Angle, K. Kallio, and O. Simell
Serum Lipid Profiles Poorly Correlate With Chlamydia pneumoniae, Helicobacter pylori, and Cytomegalovirus Seropositivity in Prospectively Followed-Up Healthy Children
Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 827 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
M. A Pereira, R. M Weggemans, D. R Jacobs Jr, P. J Hannan, P. L Zock, J. M Ordovas, and M. B Katan
Within-person variation in serum lipids: implications for clinical trials
Int. J. Epidemiol., June 1, 2004; 33(3): 534 - 541.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. M. Wasan, O. Sivak, R. A. Cote, A. I. MacInnes, K. D. Boulanger, M. Lynn, W. J. Christ, L. D. Hawkins, and D. P. Rossignol
Association of the Endotoxin Antagonist E5564 with High-Density Lipoproteins In Vitro: Dependence on Low-Density and Triglyceride-Rich Lipoprotein Concentrations
Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2796 - 2803.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
B. R Gordon, T. S Parker, D. M Levine, S. D Saal, L. C. Hudgins, B.-J. Sloan, C. Chu, K. H Stenzel, and A. L Rubin
Safety and Pharmacokinetics of an Endotoxin-Binding Phospholipid Emulsion
Ann. Pharmacother., July 1, 2003; 37(7): 943 - 950.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. H. M. Levels, P. R. Abraham, E. P. van Barreveld, J. C. M. Meijers, and S. J. H. van Deventer
Distribution and Kinetics of Lipoprotein-Bound Lipoteichoic Acid
Infect. Immun., June 1, 2003; 71(6): 3280 - 3284.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
I. Giovannini, C. Chiarla, F. Greco, G. Boldrini, and G. Nuzzo
Characterization of Biochemical and Clinical Correlates of Hypocholesterolemia after Hepatectomy
Clin. Chem., February 1, 2003; 49(2): 317 - 319.
[Full Text] [PDF]

Home page
 JPEN J Parenter Enteral NutrHome page
W. Z. Martini, O. Irtun, D. L. Chinkes, B. Rasmussen, D. L. Traber, and R. R. Wolfe
Alteration of Hepatic Fatty Acid Metabolism After Burn Injury in Pigs
JPEN J Parenter Enteral Nutr, November 1, 2001; 25(6): 310 - 316.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. E. Hak, H. A. P. Pols, C. D. A. Stehouwer, J. Meijer, A. J. Kiliaan, A. Hofman, M. M. B. Breteler, and J. C. M. Witteman
Markers of Inflammation and Cellular Adhesion Molecules in Relation to Insulin Resistance in Nondiabetic Elderly: The Rotterdam Study
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4398 - 4405.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. H. M. Levels, P. R. Abraham, A. van den Ende, and S. J. H. van Deventer
Distribution and Kinetics of Lipoprotein-Bound Endotoxin
Infect. Immun., May 1, 2001; 69(5): 2821 - 2828.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Hoffmeister, D. Rothenbacher, G. Bode, K. Persson, W. Marz, M. A. Nauck, H. Brenner, V. Hombach, and W. Koenig
Current Infection With Helicobacter pylori, but Not Seropositivity to Chlamydia pneumoniae or Cytomegalovirus, Is Associated With an Atherogenic, Modified Lipid Profile
Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 427 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
V. Mooser, M. M. Berger, L. Tappy, C. Cayeux, S. M. Marcovina, R. Darioli, P. Nicod, and R. Chiolero
Major Reduction in Plasma Lp(a) Levels During Sepsis and Burns
Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1137 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. M. Wasan, F. W. Strobel, S. C. Parrott, M. Lynn, W. J. Christ, L. D. Hawkins, and D. P. Rossignol
Lipoprotein Distribution of a Novel Endotoxin Antagonist, E5531, in Plasma from Human Subjects with Various Lipid Levels
Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2562 - 2564.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. E. Hak, C. D. A. Stehouwer, M. L. Bots, K. H. Polderman, C. G. Schalkwijk, I. C. D. Westendorp, A. Hofman, and J. C. M. Witteman
Associations of C-Reactive Protein With Measures of Obesity, Insulin Resistance, and Subclinical Atherosclerosis in Healthy, Middle-Aged Women
Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1986 - 1991.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
V. G. Cabana, C. A. Reardon, B. Wei, J. R. Lukens, and G. S. Getz
SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice
J. Lipid Res., June 1, 1999; 40(6): 1090 - 1103.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
C. Grunfeld, M. Marshall, J. K. Shigenaga, A. H. Moser, P. Tobias, and K. R. Feingold
Lipoproteins inhibit macrophage activation by lipoteichoic acid
J. Lipid Res., February 1, 1999; 40(2): 245 - 252.
[Abstract] [Full Text]

Home page
 CirculationHome page
A. Fagot-Campagna, R. L. Hanson, K. M. V. Narayan, M. L. Sievers, D. J. Pettitt, R. G. Nelson, and W. C. Knowler
Serum Cholesterol and Mortality Rates in a Native American Population With Low Cholesterol Concentrations : A U-Shaped Association
Circulation, September 2, 1997; 96(5): 1408 - 1415.
[Abstract] [Full Text]

Home page
 BMJHome page
M A Mendall, P. Patel, L. Ballam, D Strachan, and T C Northfield
C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study
BMJ, April 27, 1996; 312(7038): 1061 - 1065.
[Abstract] [Full Text]

Home page
 BMJHome page
G. Wannamethee, A G. Shaper, P. H Whincup, and M. Walker
Low serum total cholesterol concentrations and mortality in middle aged British men
BMJ, August 12, 1995; 311(7002): 409 - 413.
[Abstract] [Full Text]

Home page
 BMJHome page
M R Law, S G Thompson, and N J Wald
Assessing possible hazards of reducing serum cholesterol
BMJ, February 5, 1994; 308(6925): 373 - 379.
[Abstract] [Full Text]

Home page
 JAMAHome page
G. R. Cooper, G. L. Myers, S. J. Smith, and R. C. Schlant
Blood Lipid Measurements: Variations and Practical Utility
JAMA, March 25, 1992; 267(12): 1652 - 1660.
[Abstract] [PDF]

Home page
 JPEN J Parenter Enteral NutrHome page
T. M. Forte, O. Genzel-Boroviczeny, M. A. Austin, L. C. Kao, C. Scott, J. J. Albers, and A. E. D'Harlingue
Effect of Total Parenteral Nutrition with Intravenous Fat on Lipids and High Density Lipoprotein Heterogeneity in Neonates
JPEN J Parenter Enteral Nutr, September 1, 1989; 13(5): 490 - 500.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Association for Clinical Chemistry.